Axel Schulz | White & Case LLP International Law Firm, Global Law Practice
Axel Schulz
Axel Schulz

Axel Schulz

Partner, Brussels

T +32 2 239 25 87

T +32 2 239 26 20

E [email protected]

in LinkedIn profile

A partner in the Firm’s Brussels office, Axel Schulz’s advisory practice focuses on merger control, cartel defence and competition law disputes before the European courts.


Axel supports clients with a broad range of German and European Commission competition law matters.

He offers clients the benefit of his significant experience in this field, having handled merger control cases involving collective dominance and countervailing buyer power, as well as structural links issues in industries including aluminum, paper, energy, automotive, pharmaceuticals and medical devices.

Axel's varied sector knowledge is matched by his deep understanding of the cross-border intricacies of competition and antitrust law. The international dimension to his practice enables him to guide both domestic and multinational companies through whatever competitive issues they are faced with, regardless of their scale or multijurisdictional complexity.

Axel's significant track record in this area includes a number of high profile cases, such as 'Toshiba v. Commission' – in which the General Court of the European Union annulled in full the €90.9 million fine imposed on Toshiba by the European Commission, for its alleged participation in the Gas Insulated Switchgear cartel. He also worked on Toshiba's Cathode Ray Tube appeal, as well as the oral hearings in T-113/07 before the European Court of Justice, and the Transformers (Case COMP/39.129) hearing before the General Court.

Regularly called upon to head up teams of the Firm's lawyers, Axel is also noted for his skill in coordinating advice across multiple offices and territories, to provide his clients with clear and creative solutions to their problems.

Axel is a particularly valued resource for clients in the pharmaceutical industry. Recognized as a leading life sciences lawyer by Who's Who Legal 2012, he has developed a strong track record of helping clients with competition law issues in the fields of distribution, co-marketing, licensing and other kinds of vertical and horizontal cooperation agreements.

A respected authority on the latest competition and antitrust issues, Axel writes regularly for leading legal publications and was honored with the Institute of Competition Law's 2012 Antitrust Writing Award.

Bars and Courts

  • Munich Bar
  • Brussels Bar (E list)


  • LLM, European Law, College of Europe, Bruges
  • Law Degree, University of Konstanz
  • Diploma, University of Lyon


  • English
  • French
  • German
  • Italian


Speaking Engagements

European Pharma Law Academy "Article 101 – Vertical and Horizontal Relationships" & "Competition law and IPRs in the pharma sector", 13 September 2017: IBC, Cambridge, United Kingdom (Speaker)

Annual Seminar on Merger Control & State Aid "Merger Control of International M&A Transactions & Joint Ventures", 10-11 May 2017: Europa-Institut, Saarbrücken, Germany (Speaker)

The Global Antitrust Economics Conference "Market Manipulation in the Financial & Energy Sectors", 7 October 2016: Concurrences + Searle Center on Law, Regulation and Economic Growth at Northwestern Pritzker School of Law, Chicago, United States of America (Speaker)

Brussels Distribution Conference "Resale Price Maintenance (RPM) - Latest Cases and Developments", 1 October 2015: DBB Law, Brussels, Belgium (Panelist)

EU Competition Law Summit 2014 "Round table on Cartels & Dawn raids", 11 September 2014: QED, Brussels, Belgium (Panelist)

Vertical Agreements: Experience with Reg. 330/2010 "Online sales", 25 June 2014: IBC Legal, Brussels, Belgium (Speaker)

Pharma Patent Lifecycles "Patent Protection vs. Abuse of Dominance", 21 June 2012: C5, London, United Kingdom Presentation(Speaker)

7th Annual Conference on Parallel Trade "Parallel trade from a Competition Law Perspective — an Update", 7 February 2013: SMI, London, United Kingdom (Speaker)

Pharmaceutical Law Academy "Pharma Sector Competition Law Developments", 7 September 2011: IBC, London, United Kingdom (Speaker)

Pharma Patent Lifecycles - The Latest Regulatory Developments and Proven Successful Strategies for Patent Lifecycle Extensions in light of Recent European and US Case Law " Guidelines on Negotiating Patent Settlement Agreements ", 21–22 June 2011: C5, London, United Kingdom Presentation(Speaker)


  • "Navigating the shark-infested waters of compliance", inCompliance, September 2016 (co-author with Jacquelyn MacLennan)
  • "Asking a lot - The information demands in European merger filing are enormous", Competition Law Insight (CLI), September 2016 (co-author with Cornelius Börner)
  • "European merger control: Well-oiled machine or spluttering engine?", White & Case LLP, Insight, Global Merger Control: Charting a Route to Port, November 2015 (Co-author with Marika Harjula & James Killick)
  • "The rules on information exchanges under European competition law", Kokusai Shoji Homu (International Bussiness Law and Practice) , Vol 41, n° 5, p. 665, 2013 (co-author with P. Berghe and T. Onoki) (published in Japanese)
  • "AG Sharpston voices opinion on the standard of judicial review over fines in cartel cases", White & Case LLP, Client Alert, February 2011 (co-author with Ian Forrester QC and Mark Powell)
  • "Recent developments in relation to parallel trade in the European pharmaceuticals sector", Biotechnology and Life Sciences Sector – Strategies for Growth, Survival and Patent Protection, Financier Worldwide, January 2010 (Co-author with Ian Forrester)
  • Who is the Predator (2)? The French Competition Council's GSK Predation Decision is Overruled", Competition Law Insight, 1 July 2008 (Co-author with Pascal Berghe)
  • "French Competition Council vs. GSK France: who is the predator?", Competition Law Insight, June 2007 (Co-author with Pascal Berghe)
  • "Horizontal and Vertical Mergers in the Reformed EC Merger Control "EC Competition Law – A Critical Assessment, edited by Prof. Amato and Prof. Ehlermann, Hart Publishing, May 2007
  • European Editor (from January to December 2007), Lloyd's Law Report: Pharma

Awards & Recognition

Recommended for Antitrust law, JUVE, 2016

Mention: Competition: EU and global, Legal 500, EMEA 2016

Leading Lawyer: Life Sciences, Who's Who Legal 2012

Best Business Anticompetitive Practices Article, Antitrust Writing Awards 2012

Institute of Competition Law